Shenzhen Neptunus Bioengineering Co., Ltd.
000078.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.84B
Close$
Share Statistics
| Market cap | $3.84 Billion |
|---|---|
| Enterprise Value | $13.19 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.21 |
| Beta | 0.08 |
| Outstanding Shares | 2,631,123,257 |
Return
| Return on Equity | -78.06% |
|---|---|
| Return on Assets | -3.36% |
| Return on Invested Capital | -10.24% |
Valuation & Multiples
| P/E Ratio | -4.87 |
|---|---|
| PEG | 0.17 |
| Price to Sales | 0.17 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.56 |
| Enterprise Value to EBIT | -56.92 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0.88 |
| Debt to Equity | 11.4 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shenzhen Neptunus Bioengineering Co., Ltd.
6,734 employees
CEO: Feng Zhang Shenzhen Neptunus Bioengineering Co., Ltd. is a pharmaceutical enterprise primarily active in China, focusing on the research, development, production, and sale of various medicinal products. Its offerings span therapeutic categories suc...